Impaired insight in Alzheimer disease: Association with cognitive deficits, psychiatric symptoms, and behavioral disturbances

被引:0
|
作者
Harwood, DG
Sultzer, DL
Wheatley, MV
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA
[2] Vet Affairs Med Ctr Greater Los Angeles Healthcar, Mental Hlth Serv, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: The purpose of this study was to evaluate symptoms associated with impaired insight in patients with Alzheimer disease (AD). Background: Although unawareness of deficits is common in AD. the relation of awareness to psychiatric and behavioral disturbances has not been extensively studied. Method: We conducted a cross-sectional investigation of 91 patients with probable AD according to the criteria of the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association. Awareness of cognitive and functional deficits was measured with the Inaccurate Insight item from the Neurobehavioral Rating Scale. Psychiatric and behavioral symptoms were measured using factor scores and individual items from the Neurobehavioral Rating Scale. Global cognitive deficits were measured using the Mini-Mental State Examination (MMSE). Results: Stepwise regression analysis showed that insight was associated with MMSE score, depression/anxiety factor score, and agitation/disinhibition factor score. Variables not associated with awareness of deficits included patient age, behavioral retardation factor score, verbal output disturbance factor score, and psychosis factor score. Post hoc analyses showed a positive relation (i,e., greater insight. more symptomatology) between deficit awareness and symptoms of depressed mood and anxiety. There was a negative relation (i.e.. greater insight, less symptomatology) between insight and symptoms of hostility, agitation, inattention, and tension. In a follow-up stepwise regression analysis, increased deficit awareness was associated with a higher MMSE score, greater depressed mood, and decreased agitation. Conclusions: These findings suggest that patients with AD may experience symptoms of depressed mood in relation to increased awareness of decrements in functioning. The data also indicate that patients with poor insight demonstrate greater agitated behavior. Consistent with previous research, impaired insight was higher in the later stages of the illness.
引用
收藏
页码:83 / 88
页数:6
相关论文
共 50 条
  • [1] Anosognosia in Alzheimer's disease: Association with patient characteristics, psychiatric symptoms and cognitive deficits
    Kashiwa, Y
    Kitabayashi, Y
    Narumoto, J
    Nakamura, K
    Ueda, H
    Fukui, K
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2005, 59 (06) : 697 - 704
  • [2] Insight in Alzheimer's disease and its relation to psychiatric and behavioral disturbances
    Horning, Sheena M.
    Melrose, Rebecca
    Sultzer, David
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2014, 29 (01) : 77 - 84
  • [3] Anosognosia in People with Cognitive Impairment: Association with Cognitive Deficits and Behavioral Disturbances
    De Carolis, Antonella
    Cipollini, Virginia
    Corigliano, Valentina
    Comparelli, Anna
    Sepe-Monti, Micaela
    Orzi, Francesco
    Ferracuti, Stefano
    Giubilei, Franco
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2015, 5 (01): : 42 - 50
  • [4] The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease
    Bodick, NC
    Offen, WW
    Shannon, HE
    Satterwhite, J
    Lucas, R
    vanLier, R
    Paul, SM
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : S16 - S22
  • [5] COGNITIVE DEFICITS PRESENTlNG AS PSYCHIATRIC SYMPTOMS IN A PATIENT WITH MOYAMOYA DISEASE
    Zalonis, Ioannis
    Christidi, Fotini
    Kararizou, Evangelia
    Triantafyllou, Nikolaos I.
    Spengos, Konstantinos
    Vassilopoulos, Dimitrios
    [J]. PSYCHOLOGICAL REPORTS, 2010, 107 (03) : 727 - 732
  • [6] Awareness of deficits in mild cognitive impairment and Alzheimer's disease: Do MCI patients have impaired insight?
    Vogel, A
    Stokholm, J
    Gade, A
    Andersen, BB
    Hejl, AM
    Waldemar, G
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 17 (03) : 181 - 187
  • [7] Selegiline in treatment of behavioral and cognitive symptoms of Alzheimer disease
    Tolbert, SR
    Fuller, MA
    [J]. ANNALS OF PHARMACOTHERAPY, 1996, 30 (10) : 1122 - 1129
  • [8] The neuropsychology of insight: Impaired awareness of deficits in a psychiatric context
    McGlynn, SM
    Schacter, DL
    [J]. PSYCHIATRIC ANNALS, 1997, 27 (12) : 806 - 811
  • [9] Neural substrates of cognitive and behavioral deficits in atypical Alzheimer's disease
    von Gunten, Armin
    Bouras, Constantin
    Koevari, Enikoe
    Giannakopoulos, Panteleimon
    Hof, Patrick R.
    [J]. BRAIN RESEARCH REVIEWS, 2006, 51 (02) : 176 - 211
  • [10] Efficacy of metrifonate in improving the psychiatric and behavioral disturbances of patients with Alzheimer's disease
    Cummings, JL
    Nadel, A
    Masterman, D
    Cyrus, PA
    [J]. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2001, 14 (02) : 101 - 108